clinical trials

ViralClear appoints former Celgene exec as chair, dusts off long-shelved hepatitis C drug for Covid-19 trial
ViralClear appoints former Celgene exec as chair, dusts off long-shelved hepatitis C drug for Covid-19 trial
MedCity News
ViralClear
BioSig Technologies
merimepodib
HCV
clinical trials
COVID-19
Flag link:
Alexion plans phase 2 study of Soliris in COVID-19 in coming days: report
Alexion plans phase 2 study of Soliris in COVID-19 in coming days: report
Fierce Pharma
Alexion
COVID-19
clinical trials
Soliris
Flag link:
IQVIA launches new COVID-19 trial 'matching service' in U.S.
IQVIA launches new COVID-19 trial 'matching service' in U.S.
Fierce Biotech
IQVIA
clinical trials
COVID-19
vaccines
Flag link:
Inovio begins clinical trial of COVID-19 vaccine
Inovio begins clinical trial of COVID-19 vaccine
Pharmaforum
Innovio
vaccines
INO-4800
COVID-19
clinical trials
Flag link:
Immunomedics' Triple-Negative Breast Cancer Trial Halted Early Due to Compelling Efficacy
Immunomedics' Triple-Negative Breast Cancer Trial Halted Early Due to Compelling Efficacy
BioSpace
Immunomeedics
sacituzumab govitecan
clinical trials
breast cancer
triple negative breast cancer
Flag link:
Axsome celebrates migraine PhIII win, shifting eyes toward a pair of Q4 submissions
Axsome celebrates migraine PhIII win, shifting eyes toward a pair of Q4 submissions
Endpoints
Axsome
clinical trials
migraines
AXS-05
Flag link:
A pair of PhIII failures spells last rites for Menlo’s once-promising Merck drug
A pair of PhIII failures spells last rites for Menlo’s once-promising Merck drug
Endpoints
Menlo Therapeutics
clinical trials
serlopitant
Flag link:
Apeiron starts mid-stage trial of drug that blocks coronavirus
Apeiron starts mid-stage trial of drug that blocks coronavirus
Pharmaforum
Apeiron
clinical trials
COVID-19
APN01
Flag link:
Sanofi and Regeneron's Dupixent shows more encouraging results
Sanofi and Regeneron's Dupixent shows more encouraging results
Reuters
Sanofi
Dupixent
atopic dermatitis
clinical trials
Flag link:
Axon's Tau Vaccine Shows Promise in Phase II Alzheimer's Study
Axon's Tau Vaccine Shows Promise in Phase II Alzheimer's Study
BioSpace
Axon Neurosciences
Alzheimer's disease
clinical trials
vaccines
Flag link:
GSK's asthma biologic Nucala is one step closer to approval in key chronic rhinosinusitis population
GSK's asthma biologic Nucala is one step closer to approval in key chronic rhinosinusitis population
Endpoints
GSK
Nucala
rhinosinusitis
nasal polyps
clinical trials
Flag link:
Mallinckrodt, Novoteris’ nitric oxide will start COVID-19 trial
Mallinckrodt, Novoteris’ nitric oxide will start COVID-19 trial
Pharmaforum
Mallinckrodt
Novoteris
Health Canada
clinical trials
nitric oxide
COVID-19
Thiolanox
devices
ARDA
Flag link:
Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks?
Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks?
Motley Fool
clinical trials
pharma stocks
COVID-19
Flag link:
Aptinyx Moves Ahead With PTSD Therapy Study, Pauses 3 Other Trials
Aptinyx Moves Ahead With PTSD Therapy Study, Pauses 3 Other Trials
Xconomy
Aptinyx
clinical trials
PTSD
COVID-19
Flag link:
As Covid-19 hinders clinical trial operations, research staff are finding themselves out of work
As Covid-19 hinders clinical trial operations, research staff are finding themselves out of work
MedCity News
clinical trials
R&D
COVID-19
Flag link:
CRISPR Therapeutics braces for 'severe impact' from COVID-19 crisis
CRISPR Therapeutics braces for 'severe impact' from COVID-19 crisis
Fierce Biotech
CRISPR
CRISPR Therapeutics
COVID-19
clinical trials
Flag link:
COVID-19 not expected to 'significantly delay' Genfit's phase 3 NASH readout
COVID-19 not expected to 'significantly delay' Genfit's phase 3 NASH readout
Fierce Biotech
Genfit
NASH
clinical trials
COVID-19
elafibranor
Flag link:
Amgen sees no 'significant delays' from pandemic to novel KRAS cancer drug
Amgen sees no 'significant delays' from pandemic to novel KRAS cancer drug
Fierce Biotech
Amgen
KRAS
AMG 510
COVID-19
clinical trials
cancer
Flag link:
Reata Pharmaceuticals Says Ongoing Trials In Patients With Pulmonary Arterial Hypertension Stopped Due To High Risk Of COVID-19 To These Patients
Reata Pharmaceuticals Says Ongoing Trials In Patients With Pulmonary Arterial Hypertension Stopped Due To High Risk Of COVID-19 To These Patients
Reuters
Reata Pharmaceuticals
PAH
clinical trials
COVID-19
Flag link:
Axsome Therapeutics' Key Drug Candidate Whiffs in Phase 3 Trial
Axsome Therapeutics' Key Drug Candidate Whiffs in Phase 3 Trial
Motley Fool
Axsome Therapeutics
AXS-05
treatment-resistant depression
clinical trials
Flag link:

Pages